20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T39764 | ALK2-IN-4 | ALK2-IN-4 | |
ALK2-IN-4, a highly effective ALK2 inhibitor. | |||
T10287 | ALK2-IN-2 | ALK , TGF-beta/Smad | |
ALK2-IN-2 is a potent and selective inhibitor of activin receptor-like kinase 2 (ALK2) (IC50: 9 nM), inhibiting ALK2 700-fold more than ALK3. | |||
T40065 | ALK2-IN-4 succinate | ALK2-IN-4 succinate | |
ALK2-IN-4 succinate is a robust and effective inhibitor of ALK2. | |||
T8108 | Blu-782 | ALK2-IN-1 | ALK |
Blu-782 (ALK2-IN-1) is a activin receptor-like kinase-2 (ALK2) inhibitor ( IC50 of <10 nM) | |||
T79020 | ALK2-IN-5 | ||
ALK2-IN-5, a pyrazolopyrimidine compound, serves as an inhibitor of ALK2 and FGFR, targeting disorders linked with their activity, including cancer [1]. | |||
T1943 | ML347 | LDN 193719 | ALK , TGF-beta/Smad |
ML347 (LDN 193719)(DN193719) is a highly specific ALK1/2 inhibitor ( IC50: 46/32 nM), and the selectivity for ALK2 is >300-fold than ALK3. | |||
T1944 | LDN-214117 | ALK , TGF-beta/Smad | |
LDN-214117 is a potent and selective ALK2 inhibitor. | |||
T35694 | OD36 | OD 36,OD 36 hydrochloride,OD-36 | ALK , RIP kinase |
OD36 is a selective and potent RIPK2 inhibitor with an IC50 of 5.3 nM.OD36 inhibits ALK2 signaling and osteogenic differentiation (KD: 37 nM), and binds efficiently to the ALK2 kinase ATP pocket. | |||
T1900 | LDN-212854 | LDN212854,BMP Inhibitor III | ALK , TGF-beta/Smad |
LDN-212854 (BMP Inhibitor III), a novel BMP inhibitor, exhibits greater selectivity for BMP versus the TGF-β type I receptors; possesses differences towards ALK2(IC50=1.3 nM) versus ALK1/3 compared to other inhibitors. | |||
T1935 | LDN193189 | LDN-193189,DM-3189,LDN 193189 | ALK , TGF-beta/Smad |
LDN193189 (LDN-193189) (DM 3189) is a selective BMP signaling inhibitor, inhibiting the transcriptional activity of ALK2 and ALK3 (IC50s: 0.8/0.8/5.3/16.7 nM for ALK1/2/3/6). | |||
T1942 | DMH-1 | DMH1 | ALK , Autophagy , TGF-beta/Smad |
DMH-1 is a potent and selective BMP inhibitor. | |||
T35348 | LDN-193189 2HCl | LDN-193189 2HCl,DM-3189 2HCl | ALK , TGF-beta/Smad |
LDN-193189 2HCl (DM-3189 2HCl) is a selective BMP signaling inhibitor that inhibits ALK1,ALK2,ALK3 and ALK6, showing IC50s of 0.8 nM, 0.8 nM, 5.3 nM, and 16.7 nM, respectively, in kinase assays.LDN-193189 2HCl inhibited ... | |||
T1977 | Dorsomorphin | Compound C,BML-275 | AMPK , Autophagy , TGF-beta/Smad |
Dorsomorphin (BML-275) is an AMPK inhibitor (Ki=109 nM) that is selective and ATP-competitive. Dorsomorphin inhibits the BMP type I receptors ALK2, ALK3, and ALK6. Dorsomorphin induces autophagy, and possesses antitumor ... | |||
T1914 | K02288 | K 02288 | ALK , TGF-beta/Smad |
K 02288 is a novel small molecule inhibitor of ALK1/2/3/6. | |||
T6146 | Dorsomorphin dihydrochloride | BML-275 2HCl,Compound C dihydrochloride,Dorsomorphin (Compound C) 2HCl,Compound C 2HCl,BML-275 dihydrochloride | AMPK , Autophagy , TGF-beta/Smad |
Dorsomorphin dihydrochloride (BML-275 2HCl) is a potent, selective and ATP-competitive AMPK inhibitor (Ki: 109 nM) and does not exhibit significant activity on structurally related kinases. | |||
T6496 | Vactosertib | TEW-7197,EW-7197 | ALK , TGF-beta/Smad |
Vactosertib (EW-7197) is an orally bioavailable inhibitor of the serine/threonine kinase, transforming growth factor (TGF)-beta receptor type 1 (TGFBR1), also known as activin receptor-like kinase 5 (ALK5), with potentia... | |||
T61424 | OD36 hydrochloride | OD 36 hydrochloride,OD-36 hydrochloride | ALK , RIP kinase |
OD36 hydrochloride (OD-36 hydrochloride) is a potent RIPK2 inhibitor with an IC50 of 5.3 nM.OD36 hydrochloride is a macrocyclic inhibitor that binds efficiently to the ATP pocket of the ALK2 kinase and effectively antago... | |||
T39104 | Itacnosertib | Itacnosertib,TP-0184 | |
Itacnosertib (TP-0184) is a chemical compound that acts as an inhibitor of JAK2, ACVR1 (ALK2), and ALK5, as indicated in WO2014151871. | |||
T6158 | LDN-193189 HCl | LDN193189 Hydrochloride | ALK |
LDN-193189 HCl (LDN193189 Hydrochloride) is a selective BMP type I receptor kinases inhibitor. | |||
T81410 | Prafnosbart | DS-6016A | |
Prafnosbart (DS-6016A) is a humanized IgG1-kappa monoclonal antibody targeting ACVR1 (activin A receptor type 1, ACVRLK2, ALK2, ACVR1A, SKR1), utilized in research on bone metabolism disorders [1]. |